Literature DB >> 8593033

Pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in the neonatal macaque (Macaca nemestrina).

R D Keller1, C Nosbisch, J D Unadkat.   

Abstract

Our objective was to determine whether age effects the pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in the neonatal pig-tailed macaque (Macaca nemestrina). The drug (5 mg/kg of body weight) was administered serially as a single intravenous bolus to the same four macaques at the ages of < 1 week, 1 month, and 4 months. Plasma clearance at < 1 week of age was significantly lower (P < 0.05) than the corresponding values at 1 month and 4 months. Our data indicate that the pharmacokinetics of stavudine change significantly with age in M. nemestrina.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593033      PMCID: PMC163043          DOI: 10.1128/AAC.39.12.2829

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Pharmacokinetics of stavudine in patients with AIDS or AIDS-related complex.

Authors:  M N Dudley; K K Graham; S Kaul; S Geletko; L Dunkle; M Browne; K Mayer
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

2.  In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine.

Authors:  E M Cretton; Z Zhou; L B Kidd; H M McClure; S Kaul; M J Hitchcock; J P Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

3.  3'-Deoxythymidin-2'-ene permeation of human lymphocyte H9 cells by nonfacilitated diffusion.

Authors:  E M August; E M Birks; W H Prusoff
Journal:  Mol Pharmacol       Date:  1991-02       Impact factor: 4.436

4.  Efflux of zidovudine and 2',3'-dideoxyinosine out of the cerebrospinal fluid when administered alone and in combination to Macaca nemestrina.

Authors:  T Tuntland; R J Ravasco; S al-Habet; J D Unadkat
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

5.  Effect of age on distribution of zidovudine (azidothymidine) into the cerebrospinal fluid of Macaca nemestrina.

Authors:  A Lopez-Anaya; J D Unadkat; D F Calkins; A L Smith
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

6.  2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial.

Authors:  M J Browne; K H Mayer; S B Chafee; M N Dudley; M R Posner; S M Steinberg; K K Graham; S M Geletko; S H Zinner; S L Denman
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

7.  Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys.

Authors:  S Kaul; K A Dandekar
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

8.  Pharmacokinetics of zidovudine (azidothymidine). III. Effect of pregnancy.

Authors:  A Lopez-Anaya; J D Unadkat; L A Schumann; A L Smith
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

9.  Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.

Authors:  F D Boucher; J F Modlin; S Weller; A Ruff; M Mirochnick; S Pelton; C Wilfert; R McKinney; M J Crain; M M Elkins
Journal:  J Pediatr       Date:  1993-01       Impact factor: 4.406

10.  Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex.

Authors:  C A Knupp; W C Shyu; R Dolin; F T Valentine; C McLaren; R R Martin; K A Pittman; R H Barbhaiya
Journal:  Clin Pharmacol Ther       Date:  1991-05       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.